GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of apoptotic process |
|
|
response to organic substance | ||
negative regulation of coagulation | ||
signal transduction |
|
|
blood coagulation |
GO Term | Evidence Code | PMID |
---|---|---|
cytosol |
|
|
extracellular region |
|
|
cytoplasm | ||
external side of plasma membrane | ||
vesicle membrane |
GO Term | Evidence Code | PMID |
---|---|---|
calcium-dependent phospholipid binding | ||
phosphatidylserine binding | ||
phospholipase inhibitor activity |
|
|
calcium ion binding | ||
phospholipid binding |
|
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0080348 | Alzheimer's disease 1 | |
DOID:0080379 | nephrotic syndrome type 2 | |
DOID:0080409 | familial adenomatous polyposis 1 | |
DOID:0090016 | chromosome 5q deletion syndrome | |
DOID:0090110 | immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome | |
DOID:0090119 | ankyloblepharon-ectodermal defects-cleft lip/palate syndrome | |
DOID:0110035 | Alzheimer's disease 2 | |
DOID:0110037 | Alzheimer's disease 5 | |
DOID:0110038 | Alzheimer's disease 6 | |
DOID:0110039 | Alzheimer's disease 7 |
HPO ID | HPO Term |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0011462 | Young adult onset |
Disease ID | Disease Name |
---|---|
OMIM:614391 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115540458 | GADMO41489 | ||
100049533 | ORYLA00491 | ||
100534399 | ORENI62675 | ||
115589710 | SPAAU57364 | ||
398472 | Xenbase:XB-GENE-1007301 | ||
443760 | Xenbase:XB-GENE-17346866 | ||
493545 | Xenbase:XB-GENE-1007295 | ||
101942442 | CHRPI11594 | ||
109309325 | CROPO16843 | ||
113434697 | PSETE05431 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024